WaveMan · Form 4
Edelman Joseph insider trades
> Search tickers & screens ⌘K
LIVE

Edelman Joseph insider trades

Edelman Joseph has filed 38 Form 4s with the SEC that we hold, for LeonaBio, Inc. (LONA) (Director), Solid Biosciences Inc. (SLDB) (Director, 10% owner), MeiraGTx Holdings plc (MGTX) (Director, 10% owner) and Aldeyra Therapeutics, Inc. (ALDX) (10% owner), among 18 companies in all. Across all of them we count 25 purchases worth $99.3M and 19 sales worth $11.7M reported on Form 4. In the last 12 months: 0 purchases ($0) and 6 sales ($344.3K). The largest single trade was a purchase of 1,200,000 shares of Crinetics Pharmaceuticals, Inc. worth $23.8M, dated 2021-10-25. The first filing on our record is dated 2021-08-18 and the latest 2026-06-24.

LeonaBio, Inc. (LONA)

Director · 8 filings · 5 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-06-29P, purchase reported on Form 4270,000$807.3K2022-07-01
2022-06-30P, purchase reported on Form 41,101,362$3.3M2022-07-01
2023-12-27P, purchase reported on Form 432,134$73.3K2023-12-29
2023-12-28P, purchase reported on Form 4409,598$999.4K2023-12-29
2023-12-29P, purchase reported on Form 4163,954$390.2K2023-12-29

Solid Biosciences Inc. (SLDB)

Director, 10% owner · 6 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2025-02-19P, purchase reported on Form 45,000,000$20.1M2025-02-21

MeiraGTx Holdings plc (MGTX)

Director, 10% owner · 4 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2024-08-12P, purchase reported on Form 41,250,000$5.0M2024-08-14

Aldeyra Therapeutics, Inc. (ALDX)

10% owner · 3 filings · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-08-04P, purchase reported on Form 495,100$586.8K2022-08-08
2022-08-08P, purchase reported on Form 497,000$702.3K2022-08-10
2024-04-04P, purchase reported on Form 4140,281$655.1K2024-04-08
2024-04-05P, purchase reported on Form 437,712$178.8K2024-04-08

Adma Biologics, INC. (ADMA)

10% owner · 2 filings · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-09-23S, sale reported on Form 4780,000$990.6K2021-09-28
2021-09-28S, sale reported on Form 440,603$49.5K2021-09-30
2021-09-29S, sale reported on Form 482,505$95.7K2021-09-30
2021-09-30S, sale reported on Form 4137,495$154.0K2021-09-30

CEMI

Reporting owner · 2 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-04-21P, purchase reported on Form 470,200$31.6K2023-04-25
2023-04-24P, purchase reported on Form 439,506$17.8K2023-04-25
2023-04-25P, purchase reported on Form 4133,742$60.2K2023-04-25

CERE

Director · 2 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-08-26P, purchase reported on Form 468,047$2.1M2021-08-31
2023-10-16P, purchase reported on Form 4876,808$20.0M2023-10-17

Adagio Medical Holdings, Inc. (ADGM)

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

CRGX

Reporting owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-11-14P, purchase reported on Form 4333,333$5.0M2023-11-14

Crinetics Pharmaceuticals, Inc. (CRNX)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2021-10-25P, purchase reported on Form 41,200,000$23.8M2021-10-25

ISO

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2021-10-12P, purchase reported on Form 4850,000$12.8M2021-10-14

LABP

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Lyra Therapeutics, Inc. (LYRA)

10% owner · 1 filing · 6 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-11-06S, sale reported on Form 428,902$149.7K2025-11-10
2025-11-06S, sale reported on Form 43,247$16.8K2025-11-10
2025-11-07S, sale reported on Form 41,993$9.5K2025-11-10
2025-11-07S, sale reported on Form 417,746$84.3K2025-11-10
2025-11-10S, sale reported on Form 41,869$8.5K2025-11-10
2025-11-10S, sale reported on Form 416,633$75.5K2025-11-10

RAIN (RAIN)

10% owner · 1 filing · 7 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-10-07S, sale reported on Form 413,082$193.6K2021-10-13
2021-10-07S, sale reported on Form 4286$4.3K2021-10-13
2021-10-08S, sale reported on Form 45,038$65.0K2021-10-13
2021-10-08S, sale reported on Form 42,462$33.6K2021-10-13
2021-10-11S, sale reported on Form 412,475$150.1K2021-10-13
2021-10-11S, sale reported on Form 49,351$123.0K2021-10-13
2021-10-12S, sale reported on Form 47,306$97.9K2021-10-13

SLNO

10% owner · 1 filing · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-05-24P, purchase reported on Form 425,000$137.0K2023-05-26
2023-05-25P, purchase reported on Form 437,500$194.2K2023-05-26
2023-05-26P, purchase reported on Form 422,500$118.6K2023-05-26

VBIV

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2021-12-01S, sale reported on Form 42,707,463$9.0M2021-12-03

Verrica Pharmaceuticals Inc. (VRCA)

10% owner · 1 filing · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-12-27P, purchase reported on Form 479,726$574.0K2023-12-29
2023-12-28P, purchase reported on Form 4126,116$892.9K2023-12-29
2023-12-29P, purchase reported on Form 4115,774$838.2K2023-12-29

Yarrow Bioscience, Inc. (VYNE)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2021-08-16S, sale reported on Form 4250,000$435.0K2021-08-18
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1164426) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms